Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis
Expanded Access requests from treating physicians may be submitted at www.pfizercares.com ; availability will depend on location/country.
Drug: abrocitinib
Must have severe uncontrolled atopic dermatitis refractory to other available treatments
Pfizer Cares
pfizercares@pfizer.com